Previous studies have shown that patients with Dravet syndrome with SCN1A mutations respond well to KD (21, 24), as did a patient with an SCN2A mutation who was treated with a modified Atkins diet (19). This evidence concerns the gene SCN2A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.